FATE - Fate Therapeutics GAAP EPS of -$0.54 beats by $0.06 revenue of $0.93M misses by $4.81M August, 08 2023 04:16 PM Fate Therapeutics Inc. 2023-08-08 16:16:44 ET Fate Therapeutics press release ( NASDAQ: FATE ): Q2 GAAP EPS of -$0.54 beats by $0.06 . Revenue of $0.93M (-95.0% Y/Y) misses by $4.81M . For further details see: Fate Therapeutics GAAP EPS of -$0.54 beats by $0.06, revenue of $0.93M misses by $4.81M